| Arina D Golubeva-ganeles, MD | |
|
700 Cass St. Suite 128, Monterey, CA 93940 | |
| (831) 920-3222 | |
| (831) 920-3245 |
| Full Name | Arina D Golubeva-ganeles |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 43 Years |
| Location | 700 Cass St. Suite 128, Monterey, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790739191 | NPI | - | NPPES |
| ZZZ13460Z | Other | MEDICARE GROUP# | |
| 00A771000 | Medicaid | CA | |
| GR0080140 | Other | CA | MEDICAID GROUP # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A77100 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital Of The Monterey Peninsula | Monterey, CA | Hospital |
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
The nine House Democrats from Texas want the Center for Medicare and Medicaid Services to reject their state's request that Medicaid beneficiaries get their prescription drugs through managed care plans.
The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists' Collaboration.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Mouth infections are currently regarded as the main reason why dental implants fail. A piece of research by the UPV/EHU has succeeded in developing coatings capable of preventing potential bacterial infection and should it arise, eliminate it as well as providing implants with osseointegrating properties, in other words, ones that facilitate anchoring to the bone.
› Verified 4 days ago
| Entity Name | Arina Ganeles Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356884571 PECOS PAC ID: 0749563385 Enrollment ID: O20170206002550 |
News Archive
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
The nine House Democrats from Texas want the Center for Medicare and Medicaid Services to reject their state's request that Medicaid beneficiaries get their prescription drugs through managed care plans.
The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists' Collaboration.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Mouth infections are currently regarded as the main reason why dental implants fail. A piece of research by the UPV/EHU has succeeded in developing coatings capable of preventing potential bacterial infection and should it arise, eliminate it as well as providing implants with osseointegrating properties, in other words, ones that facilitate anchoring to the bone.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arina D Golubeva-ganeles, MD 700 Cass St. Suite 128, Monterey, CA 93940 Ph: (831) 920-3222 | Arina D Golubeva-ganeles, MD 700 Cass St. Suite 128, Monterey, CA 93940 Ph: (831) 920-3222 |
News Archive
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
The nine House Democrats from Texas want the Center for Medicare and Medicaid Services to reject their state's request that Medicaid beneficiaries get their prescription drugs through managed care plans.
The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists' Collaboration.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
Mouth infections are currently regarded as the main reason why dental implants fail. A piece of research by the UPV/EHU has succeeded in developing coatings capable of preventing potential bacterial infection and should it arise, eliminate it as well as providing implants with osseointegrating properties, in other words, ones that facilitate anchoring to the bone.
› Verified 4 days ago
Dr. Steven Michael Lome, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Garden Ct, Monterey, CA 93940 Phone: 831-647-1123 Fax: 831-886-3647 | |
Nancy Rubin, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Harris Ct, Bldg T, 2nd Fl Suite 201, Monterey, CA 93940 Phone: 831-375-4105 | |
Dr. Mitsuyo Kohama, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 23625 Wr Holman Hwy, Monterey, CA 93940 Phone: 831-622-2708 Fax: 831-622-2709 | |
Michael Ernst-georg Jesinger, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Garden Ct, Monterey, CA 93940 Phone: 831-647-1123 Fax: 831-886-3647 | |
Yosuf Walid Subat, MD, MPH Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Upper Ragsdale Dr Bldg A, Monterey, CA 93940 Phone: 831-333-3040 | |
Jose Ishmael Mendez, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 23625 Wr Holman Hwy, Monterey, CA 93940 Phone: 831-622-2708 Fax: 831-622-2709 | |
Roger Shiffman, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Harris Ct, Bldg T, 2nd Floor Suite 201, Monterey, CA 93940 Phone: 831-375-4105 Fax: 831-372-5722 |